Interactive course ideal for anyone with responsibility for planning or delivering training in the Pharma, Device or Animal Health Industries (including GXP and SOP training to comply with EU and FDA inspection requirements).
22-23 Oct 2019
This intensive course will enable you to understand how to train others effectively through interactive discussions, exercises and practical examples. Using a proven and best practice framework for training, this programme will equip you with the confidence, skills, techniques and knowledge to design, deliver, evaluate, identify training needs and implement a successful training strategy in your role. There will be plenty of opportunity for sharing experiences and best practice training approaches with other participants during group discussions.
This course is designed for all those who have responsibilities for planning, organising or delivering training within the pharmaceutical, device or animal health industries, or study site. It will be ideal for those who need to carry out some training as part of their role, those new to a training role as well as those who may wish to refresh and develop their existing skills.
Maximise the effectiveness of your training
Regulatory compliance to meet inspector’s requirements
Training needs analysis, developing a training strategy and training plans for compliance in the pharma industry
Planning and designing a training programme in the pharma industry to ensure compliance
Delivering training to high standards
Interactive sessions for GxP / SOP and technical training
Evaluation of training
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.